|
0
|
|
Virologic insights from the phase 3 REDPINE trial: remdesivir in renally impaired and immunocompromised patients with COVID-19.
(journals.asm.org)
|
Rodriguez L
…
Hedskog C
Antimicrobial Agents and Chemotherapy
2026-07-10
|
#covid-19
#antiviral
#amr
#immunocompromised
#sequencing
|
|
0
|
|
Preclinical characterization of HEC116094, an oral inhibitor of the influenza A virus polymerase PB2 subunit.
(tandfonline.com)
|
Nie L
…
Zhang L
Emerging Microbes & Infections
2026-07-10
|
#influenza
#antiviral
#preclinical
#inhibitor
#amr
|
|
0
|
|
HBsAg seroreversion after pegylated interferon alpha induced HBsAg seroclearance in patients with chronic hepatitis B: a real-world cohort study.
(link.springer.com)
|
Zhang W
…
Song J
BMC Infectious Diseases
2026-07-10
|
#hepatitis
#immunotherapy
#seroreversion
#antiviral
#prognosis
|
|
0
|
|
A host-centric morphological profiling approach to identify repurposed antiviral drugs.
(linkinghub.elsevier.com)
|
Asp E
…
Ostling P
iScience
2026-07-10
|
#antiviral
#drug-repurposing
#morphological-profiling
#host-directed therapy
#screening
|